Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
PLoS One. 2011;6(12):e28130. doi: 10.1371/journal.pone.0028130. Epub 2011 Dec 9.
Use of a risk of bias (ROB) tool has been encouraged and advocated to reviewers writing systematic reviews (SRs) and meta-analyses (MAs). Selective outcome reporting and other sources of bias are included in the Cochrane ROB tool. It is important to know how this specific tool for assessing ROB has been applied since its release. Our objectives were to evaluate whether and to what extent the new Cochrane ROB tool has been used in Chinese journal papers of acupuncture.
We searched CBM, TCM database, CJFD, CSJD, and the Wanfang Database from inception to March 2011. Two reviewers independently selected SRs that primarily focused on acupuncture and moxibustion, from which the data was extracted and analyzed.
A total of 836 SRs were identified from the search, of which, 105 were included and four are awaiting assessment. Thirty-six of the 105 SRs were published before release of the Cochrane ROB tool (up to 2009). Most used the Cochrane Handbook 4.2 or Jadad's scale for risk or quality assessment. From 2009 to March 2011 69 SRs were identified. While "risk of bias" was reported for approximately two-thirds of SRs, only two SRs mentioned use of a "risk of bias tool" in their assessment. Only 5.8% (4/69) of reviews reported information on all six domains which are involved in the ROB tool. A risk of bias graph/summary figure was provided in 2.9% (2/69) of reviews. Most SRs gave information about sequence generation, allocation concealment, blindness, and incomplete outcome data, however, few reviews (5.8%; 4/69) described selective reporting or other potential sources of bias.
The Cochrane "risk of bias" tool has not been used in all SRs/MAs of acupuncture published in Chinese Journals after 2008. When the ROB tool was used, reporting of relevant information was often incomplete.
使用偏倚风险(ROB)工具已被鼓励并推荐给撰写系统评价(SRs)和荟萃分析(MAs)的评审者。Cochrane ROB 工具包括选择性报告结果和其他偏倚来源。了解该特定 ROB 评估工具发布以来的应用情况非常重要。我们的目标是评估新的 Cochrane ROB 工具在中国针灸期刊论文中是否以及在何种程度上得到了应用。
我们从建库至 2011 年 3 月检索了 CBM、TCM 数据库、CJFD、CSJD 和万方数据库。两位评审员独立选择主要关注针灸的 SRs,并从中提取和分析数据。
从检索中总共确定了 836 篇 SRs,其中 105 篇被纳入,4 篇正在评估中。105 篇 SRs 中有 36 篇发表于 Cochrane ROB 工具发布之前(截至 2009 年)。大多数使用 Cochrane 手册 4.2 或 Jadad 量表进行风险或质量评估。2009 年至 2011 年 3 月期间,确定了 69 篇 SRs。大约有三分之二的 SRs报告了“偏倚风险”,但只有两篇 SRs在其评估中提到使用了“偏倚风险工具”。只有 5.8%(69 篇中的 4 篇)的综述报告了 ROB 工具涉及的六个领域的所有信息。在 2.9%(69 篇中的 2 篇)的综述中提供了偏倚风险图表/总结图。大多数 SRs提供了关于随机序列生成、分配隐藏、盲法和不完整结局数据的信息,但很少有综述(5.8%;69 篇中的 4 篇)描述了选择性报告或其他潜在的偏倚来源。
在 2008 年后发表在中国期刊上的针灸 SRs/MAs 中,并非所有的都使用了 Cochrane“偏倚风险”工具。当使用 ROB 工具时,相关信息的报告往往不完整。